Skip to main content
Clinical Trials/NCT06761196
NCT06761196
Recruiting
Not Applicable

Assessing Quality of Life After Breast Cancer Surgery: a Prospective Cohort Study

Centre Hospitalier de Colmar1 site in 1 country1,500 target enrollmentSeptember 2, 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer Surgery
Sponsor
Centre Hospitalier de Colmar
Enrollment
1500
Locations
1
Primary Endpoint
Quality of life measured with BREAST-Q
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The goal of this observational study is to prospectively collect data on quality of life after oncoplastic breast surgery.

Participants will be followed-up and answer quality of life questionnaire for a duration of 5 years after surgery.

Registry
clinicaltrials.gov
Start Date
September 2, 2025
End Date
September 1, 2035
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Centre Hospitalier de Colmar
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient aged 18 or over
  • Patient with breast cancer of any stage (including in situ) or healthy individual at high personal risk.
  • Patient requiring breast surgery under general anesthesia, whether for therapeutic or prophylactic purposes.
  • Patient capable, in the opinion of the investigator, of complying with the requirements and restrictions of the study.
  • Patient with a computer, tablet or smartphone connected to the Internet.
  • Patient followed in the center on a regular basis according to standard recommendations.

Exclusion Criteria

  • Patient requiring surgical intervention under local anesthesia only.
  • Patient requiring surgery for the installation or removal of an chemotherapy implantable port only.
  • Patients with a history of cancer other than breast cancer. Patients with a history of cancer more than three years old are eligible if they are treated and considered cured. Patients with a history of cervical carcinoma in situ or non-melanoma skin carcinoma are eligible.
  • Impossibility of being subject to regular monitoring for geographical, social or psychological reasons.
  • Patient under protective measure

Outcomes

Primary Outcomes

Quality of life measured with BREAST-Q

Time Frame: From enrollment to the end of 5 years follow-up

The BREAST-Q is a rigorously developed patient-reported outcome measure for use in cosmetic and reconstructive breast surgery and clinical practice. The BREAST-Q conceptual framework covers 2 domains: quality of life, and patient satisfaction. There is three independent modules developped for breast cancer (mastectomy, breast-conserving therapy, reconstruction). A conversion table is used to convert the raw scale summed score into a score from 0 (worst) to 100 (best). Higher scores reflect a better outcome.

Secondary Outcomes

  • Quality of life measured with EORTC QLQ C30(From enrollment to the end of 5 years follow-up)
  • Quality of life measured with EORTC QLQ-BR42(From enrollment to the end of 5 years follow-up)
  • Safety of postoperative period(Form enrollment to the end of 5 years follow-up)
  • Quality of postoperative period(At enrollment aund day 1 and 7 after surgery)

Study Sites (1)

Loading locations...

Similar Trials